论文部分内容阅读
对天津市药品不良反应监测中心2005年收集的97份《药品不良反应/事件定期汇总表》的质量进行审核分析,提示药品生产企业在提高报表质量的同时,更应定期加强对其产品安全性的全面考察。
The auditing and analysis of the quality of 97 “periodic reports of ADRs / Events” collected by Tianjin Center for Drug Adverse Reaction Monitoring in 2005 indicated that while the drug manufacturers should improve the quality of their reports, they should also strengthen their product safety regularly Comprehensive inspection.